03 February 2006

African 'biopiracy' debate heats up

Talent Ngandwe
2 February 2006
Source: SciDev.Net

[LUSAKA] The debate is intensifying over how local communities should share the benefits of research based on Africa's biodiversity while protecting the intellectual property rights of the researchers involved.
As the UN Convention on Biological Diversity meets in Spain this week for international negotiations on this and other issues, some environmental groups say it should declare a moratorium on foreign researchers using biological resources until it can sort out rules on how benefits can be shared fairly.
"It's about cases of biopiracy or, to use the more old-fashioned term, theft," says Jay McGown, author of the report released on Monday (30 January) by the US-based Edmonds Institute and the African Centre for Biosafety, South Africa.
But some of the companies the report names say the study is flawed and shows poor understanding of how products are researched and developed. They point out that such research can benefit developing countries by, for instance, producing drugs against neglected diseases.
The report describes 34 recent examples of Western laboratories developing drugs, cosmetics and industrial products using material from African plants, animals or microbes.
"It's unbelievable how much has been taken without public accounting, and probably without any permission from the communities involved," says Mariam Mayet, executive director of the African Centre for Biosafety.
"Biopiracy is rampant," agrees Lloyd Thole, executive secretary of Zambia's National Science and Technology Council. He told SciDev.Net that a policy on indigenous knowledge, genetic resources and benefit sharing would be presented to the Zambian cabinet this year.
The report cites the example of an appetite suppressant developed and patented by the South African Council for Scientific and Industrial Research from the Hoodia cactus, used traditionally by the indigenous San people for the same purpose.
The council sold exclusive rights to a British company to develop a weight loss drug. Only after a public outcry about the lack of benefit sharing with the San was a deal brokered that pledged a percentage of royalties to them (see Bushmen to share gains from 'slimming cactus').
At the time, the council's director general described the agreement as a model of engagement between a high-level research institution and an indigenous community, but the authors of this week's report describe the royalties as "miniscule".
The report also describes a patent held by UK-based SR Pharma on the use of a bacterium isolated in Uganda to treat chronic infections, including HIV/AIDS.
But Iain Ross, the company's chair, told SciDev.Net that the bacterium occurs worldwide, and is just one of many that researchers are assessing as potential sources of drugs to treat diseases in the developing world. He added that the US National Institutes of Health are funding trials in Tanzania to see whether the microbe can be used to treat tuberculosis.
"The report's authors didn't do their research properly," says Ross. "They imply that SR Pharma went to Africa and stole something, which isn't true."
Ross told SciDev.Net that the company has spent more than US$50 million researching the bacterium's potential but has "never made any money".
Also named in the report is Anne Wright of US-based Harbor Branch Oceanographic Institution.
She says that before starting any research, her team "works with the government, appropriate agencies and scientists within the country of origin to obtain informed consent for the work and to obtain all required permits for collecting and exporting specimens."
"I remain hopeful that one of our compounds will be developed into a marketable drug," she told SciDev.Net. "In such a case there will be a monetary return to the source country, funding to allow our research to continue and a new treatment for a dreadful disease. I think that would be a win-win situation."
The report also questions whether the US-based universities of Texas and Georgia should have been able to patent a product for treating sunburn that is based on extracts of tamarind seeds. Tamarind is native to Africa, and its seeds have been used traditionally to treat a range of disorders, including burns.
But Jim Arie, director of the Centre for Technology Development at the University of Texas, told SciDev.Net that exclusive rights to intellectual property do limit access to products by patients in developing countries.
He added that his university agrees that rules should be ratified to eliminate these barriers and to ensure that patents do not impede research on neglected diseases in these countries.
Link to full report Out of Africa: Mysteries of access and benefit sharing


Anonymous said...

I appreciate, lead to I discovered exactly what I
was having a look for. You've ended my four day long hunt! God Bless you man. Have a nice day. Bye

My web-site real hoodia

Anonymous said...

I always emailed this weblog post page to all my contacts,
since if like to read it then my links will too.

Also visit my webpage www.capitole-concours.fr

Anonymous said...

Hi there just wanted to give you a quick heads up. The text in your article
seem to be running off the screen in Opera.
I'm not sure if this is a formatting issue or something to do with web browser compatibility but I figured I'd post to let you know.
The layout look great though! Hope you get the problem fixed soon.

Feel free to surf to my webpage; buy volume pills

Anonymous said...

It's enormous that you are getting thoughts from this article as well as from our dialogue made at this time.

My homepage: where can i buy semenax

Anonymous said...

I read this article completely on the topic of the comparison
of newest and previous technologies, it's amazing article.

My web page: buy eazol

Anonymous said...

Wow that was strange. I just wrote an really long comment but after I clicked submit my comment didn't appear. Grrrr... well I'm
not writing all that over again. Regardless, just wanted to say great blog!

Feel free to visit my site :: www.peterdschalin.com

Anonymous said...

I rarely leave a response, however i did a few searching and wound up here "African 'biopiracy' debate heats up".
And I actually do have a few questions for you if you tend not to mind.

Could it be just me or does it look as if like some of the responses
appear as if they are written by brain dead individuals?

:-P And, if you are posting at other social sites, I would like to keep up with everything new
you have to post. Would you list of the complete urls
of all your community pages like your linkedin profile, Facebook page or
twitter feed?

my blog - buy virility ex

Anonymous said...

I loved as much as you'll receive carried out right here. The sketch is attractive, your authored material stylish. nonetheless, you command get bought an nervousness over that you wish be delivering the following. unwell unquestionably come more formerly again as exactly the same nearly very often inside case you shield this hike.

Also visit my webpage :: miroverve review

Anonymous said...

Your style is very unique compared to other folks I've read stuff from. I appreciate you for posting when you have the opportunity, Guess I'll just bookmark this web

my web-site proactol review

Anonymous said...

When I originally commented I seem to have
clicked the -Notify me when new comments are added- checkbox and now every time a comment is
added I get 4 emails with the exact same comment.
Perhaps there is an easy method you can remove me from that service?
Thanks a lot!

My webpage - Capsiplextruth.Net

Anonymous said...

Hello there! I simply want to offer you a big thumbs up for the excellent info you have got here
on this post. I will be coming back to your website for more soon.

Also visit my webpage onychomycosis treatment

Anonymous said...

Hey would you mind letting me know which web host you're utilizing? I've loaded your blog in
3 different internet browsers and I must say this blog loads
a lot quicker then most. Can you recommend a good web hosting provider at a reasonable
price? Kudos, I appreciate it!

Feel free to visit my web blog :: virility ex [universityrep.info]